- Nachrichtendetail
-
11.07.2024 13:22:34 - dpa-AFX: *PFIZER ADVANCES DEVELOPMENT OF ONCE-DAILY FORMULATION OF ORAL GLP-1 RECEPTOR AGONIST DANUGLIPRON
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Pfizer | 852009 | NYSE | 30,865 | 31.07.24 20:49:48 | -0,525 | -1,67% | 30,860 | 30,870 | 31,200 | 31,390 |
